Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT00862641

Public ClinicalTrials.gov record NCT00862641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is intended to determine the safety and tolerance of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.

Study identification

NCT ID
NCT00862641
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
1,009 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2009 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Sep 18, 2012

2009

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
Not listed Montgomery Alabama 36117 —
Not listed Anaheim California 92801 —
Not listed Encinitas California 92024 —
Not listed Fullerton California 92835 —
Not listed Huntington Beach California 92647 —
Not listed Long Beach California 90806 —
Not listed Mission Viejo California 92691 —
Not listed Roseville California 95661 —
Not listed San Diego California 92120 —
Not listed San Diego California 92123 —
Not listed Santa Ana California 92704 —
Not listed Waterbury Connecticut 06708 —
Not listed Newark Delaware 19713 —
Not listed Wilmington Delaware 19807 —
Not listed Clearwater Florida 33756 —
Not listed DeLand Florida 32720 —
Not listed Miami Florida 33173 —
Not listed Trinity Florida 34655 —
Not listed Winter Park Florida 32789 —
Not listed Stockbridge Georgia 30281 —
Not listed Aurora Illinois 60504 —
Not listed Topeka Kansas 66606 —
Not listed Shreveport Louisiana 71104 —
Not listed Auburn Maine 04210 —
Not listed No. Dartmouth Massachusetts 02747 —
Not listed Minneapolis Minnesota 55402 —
Not listed Plymouth Minnesota 55441 —
Not listed St Louis Missouri 63141 —
Not listed Papillion Nebraska 68046 —
Not listed Brick New Jersey 08723 —
Not listed Raleigh North Carolina 27607 —
Not listed Chardon Ohio 44024 —
Not listed Cincinnati Ohio 45206 —
Not listed Cincinnati Ohio 45231 —
Not listed Oklahoma City Oklahoma 73103 —
Not listed Medford Oregon 97504 —
Not listed Upland Pennsylvania 19013 —
Not listed Providence Rhode Island 02906 —
Not listed Charleston South Carolina 29407 —
Not listed Easley South Carolina 29640 —
Not listed Greenville South Carolina 29615 —
Not listed Spartanburg South Carolina 29303 —
Not listed Knoxville Tennessee 37920 —
Not listed Dallas Texas 75231 —
Not listed Houston Texas 77074 —
Not listed New Braunfels Texas 78130 —
Not listed San Antonio Texas 78229 —
Not listed Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00862641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2012 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00862641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →